Scott Chadderdon is a Cardiology physician affiliated with Oregon Health & Science University. OpenAlex indexes 128 publications with 2,582 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Portland, OR 972393011
Telephone
503-494-8750Registry record last updated 10 Dec 2013.
Clinical trials
- Physical Activity and Obesity
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202551 payments$36,862openpaymentsdata.cms.gov ↗
- GE HEALTHCAREProgram year20256 payments$19,489openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year202535 payments$18,264openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transcatheter Tricuspid Valve Replacement in Patients With Cardiac Implantable Electronic Device Leads
JACC. Clinical electrophysiology
2026 - Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial
European Heart Journal
2025 - Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement
JACC: Cardiovascular Interventions
2025 - Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement
JACC: Cardiovascular Interventions
2025 - Residual Mitral Regurgitation Interacts With Transmitral Mean Pressure Gradient to Modify the Association With Mortality Following Transcatheter Edge-to-Edge Repair
Circulation Cardiovascular Interventions
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”